Hepcinat Lp

HEPCINAT LP TABLET 28s Price India | Buy Online Hepcinat Lp Price, Dealers , Exporters of Hepcinat Lp in India, HEPCINAT LP TABLET 28s Price India.

What is Hepcinat Lp?

Hepcinat-LP Tablets is a formulation combination of anti-viral medications Ledipasvir and Sofosbuvir used in the treatment of Chronic Hepatitis C Virus (CHCV) infection genotype 1. Hepcinat-LP is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase.
The international brand name of this medicine is Harvoni that provides effective treatment in Hepatitis C Genotype 1 with a cure rate ranging between 94% to 99%. Hepcinat-LP helps prevent Hepatitis C Virus infection from multiplying in your body by weakening the virus and inhibiting its reproduction and replication.
Colours: Ferric Oxide (Yellow) USP/F & Titanium Dioxide USP

Hepcinat LP (Ledipasvir & Sofosbuvir)
Brand name: Hepcinat LP
Active Ingeridents(Generic Name) : Ledipasvir & Sofosbuvir
Company Name: Natco
Package: 28 tablets/bottle
Strength : Ledipasvir 90mg,& Sofosbuvir,400mg

Description of Hepcinat-LP

Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. HARVONI (Gilead Sciences, Inc.) is a prescription medicine which contains a combination of Sofosbuvir and Ledipasvir in the dosages form of 90mg and 400 mg that is used for treatment of Chronic Hepatitis C (CHC) genotype 1 infection in adults. It is not recognized yet if HARVONI is safe and effective medicine for children under 18 years of age.
Genotype 1 HCV is the most common infection accounting for 70 to 75% of the entirely Hepatitis C infections in the UNITED STATES. Ledipasvir and Sofosbuvir are antiviral medications that help to prevent hepatitis C virus (HCV) cells from multiplying in your body.
The Indian generic of HARVONI to be manufactured by NATCO PHARMA LIMITED is available now in INDIA under the trade name HEPCINAT-LP. This drug also have similar effects as HARVONI in treating Chronic Hepatitis C (CHC) genotype 1 infection in adults. The recommended dosage of Hepcinat-LP is one tablet taken orally once daily with or without food.

Dosage & Administration

Hepcinat-LP is to be administered under the strict supervision of a Hepatologist only.
* Hepcinat-LP is to be taken by adults over 18 years of age only.
* Hepcinat-LP is to be taken orally with a full glass of water.
* The maximum recommended dosing frequency is once per day.
* To be taken at the same time every day (24 hour gap).
* Hepcinat-LP's length of treatment may vary for a period between 8 weeks to 24 weeks.
* Do not stop use and intake of other anti-viral medications alongside Hepcinat unless instructed by your doctor.
Important - The correct dosage and prescription commonly depend on the patient and the condition being treated. Duration of dosage can range between 8 weeks to 24 weeks and the correct duration of treatment is to be determined by your medical practitioner or doctor as it will depend on the patient's condition and their response to the therapy. Do not adjust your dosage without the approval of your medical practitioner or doctor. This product is only for use as prescribed and instructed by a doctor or medical practitioner.

Side Effects

Hepcinat-LP's active ingredients are Ledipasvir & Sofosbuvir which may have reported side effects as under:
* Common Side Effects / Symptoms - Consult your doctor or medical practitioner if you experience any common side effects or symptoms such as nausea, diarrhea, headache, loss of appetite, lower back pain, side pain, insomnia (sleeplessness) and/or fever.
* Serious Side Effects / Symptoms - Discontinue use of Hepcinat-LP and contact your emergency medical centre right away if you experience any signs of pale skin, hives, rashes, edema (swelling), mood changes, excessive fatigue, behaviour changes, irregular heartbeat, breathing difficulty, breathlessness, swallowing difficulty and/or signs of any infection.
* Unknown Side Effects / Symptoms: Hepcinat-LP may cause other unknown side effects or symptoms not listed here. For complete information, discuss the use of Hepciant-LP with your doctor or healthcare medical practitioner before use.

Mechanism of Action

Harvoni (Ledipasvir 90mg & Sofosbuvir 400mg) - Ledipasvir inhibits NS5A, an important phosphoprotein, which is involved in viral replication, assembly and secretion. Resistance selection in cell culture and cross-resistance studies indicates Ledipasvir aims NS5A as its mode of action.
Sofosbuvir is an inhibitor of the HCV NS5B - the key enzyme mediating HCV RNA replication. Virus needs RNA molecule to reproduce, and Sofosbuvir prevents this RNA molecule from forming.
Ledipasvir & Sofosbuvir work synergetically to weaken Hepatitis C replication. In such a way, virus is weakened. Immune system does the rest.

Availability in India

HEPCINAT-LP comes in the category of prescription drugs that is also categorized in the list of prescription medicines but in order to dispense this particular drug, there is a legal requirement of a medical prescription. The drug can be made available in all the major cities of India. The confirmation of the order of this particular drug will be made after the valid prescription from Hepatologist or HCV treatment specialist.